Cargando…

Association between direct-acting oral anticoagulants vs. warfarin with the risk of osteoporosis in patients with non-valvular atrial fibrillation

Detalles Bibliográficos
Autores principales:	Akhtar, Tauseef, Hajra, Adrija, Bhyan, Poonam, Ghosh, Raktim K., Bandyopadhyay, Dhrubajyoti, Aronow, Wilbert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154295/ https://www.ncbi.nlm.nih.gov/pubmed/32309531 http://dx.doi.org/10.1016/j.ijcha.2020.100484

Ejemplares similares

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Novel imaging modalities to predict the development of atrial fibrillation post stroke
por: Faisaluddin, Mohammed, et al.
Publicado: (2018)

Effect of diabetic ketoacidosis on the outcomes of ST-elevation myocardial infarction: An analysis of national inpatient sample
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)

Impact of atrial fibrillation in patients with lung cancer: Insights from National Inpatient Sample
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)

Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2018)

Impact of pulmonary hypertension in patients undergoing atrial fibrillation ablation: A nationwide study
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)

Effects of inflammatory bowel disease on in-hospital outcomes in patients with congestive heart failure: A retrospective national inpatient sample study
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2019)

Safety and Efficacy of Extremely Low LDL-Cholesterol Levels and Its Prospects in Hyperlipidemia Management
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2018)

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

Screening for diabetic retinopathy: New methods to come
por: Hajra, Adrija, et al.
Publicado: (2016)

Patent Foramen Ovale and Migraine: Casual or Causal
por: Hajra, Adrija, et al.
Publicado: (2016)

Anti-N-methyl-d-aspartate receptor encephalitis: A challenge to diagnose in children
por: Hajra, Adrija, et al.
Publicado: (2016)

Recent trial on Vitamin D: Higher dose increases fall?
por: Hajra, Adrija, et al.
Publicado: (2016)

Management of Thrombotic Complications in COVID-19: An Update
por: Hajra, Adrija, et al.
Publicado: (2020)

COVID-19 Pandemic: Cardiovascular Complications and Future Implications
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2020)

Zika Virus: A Global Threat to Humanity: A Comprehensive Review and Current Developments
por: Hajra, Adrija, et al.
Publicado: (2016)

Future in neuromedicine: Nanotechnology
por: Hajra, Adrija, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis: promising therapeutic outcome–not far away?
por: Hajra, Adrija, et al.
Publicado: (2016)

Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
por: Birkinshaw, Alexander, et al.
Publicado: (2020)

Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study)
por: Dalmau Llorca, M. Rosa, et al.
Publicado: (2021)

In-hospital clinical outcomes of transcatheter aortic valve replacement in patients with concomitant carotid artery stenosis: Insights from the national inpatient sample
por: Chakraborty, Sandipan, et al.
Publicado: (2020)

Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
por: Briasoulis, Alexandros, et al.
Publicado: (2018)

Cardiac Tamponade as Initial Presentation of Hodgkin Lymphoma
por: Hajra, Adrija, et al.
Publicado: (2015)

Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis
por: Tummala, Ramyashree, et al.
Publicado: (2022)

Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis
por: de Souza Lima Bitar, Yasmin, et al.
Publicado: (2019)

An intriguing relation between atrial fibrillation and contrast-induced nephropathy
por: Ashish, Kumar, et al.
Publicado: (2018)

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non‐valvular atrial fibrillation and heart failure
por: Martinez, Brandon K., et al.
Publicado: (2018)

Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation
por: Balcı, Kevser Gülcihan, et al.
Publicado: (2016)

Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D
por: Welander, Frida, et al.
Publicado: (2023)

SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S(4)-BOW-AF)
por: Harris, Daniel E, et al.
Publicado: (2023)

Prescribers’ perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
por: Generalova, Daria, et al.
Publicado: (2020)

Sacubitril/valsartan averts post-myocardial infarction ventricular remodeling and preserves heart function
por: Hajra, Adrija, et al.
Publicado: (2019)

Etripamil: Self-management of supraventricular tachycardia is not far away?
por: Faisaluddin, Mohammed, et al.
Publicado: (2019)

Prognostic value of global longitudinal strain in heart failure subjects: A recent prototype
por: Ashish, Kumar, et al.
Publicado: (2018)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Publicado: (2020)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
por: Huang, Huei‐Kai, et al.
Publicado: (2020)

Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
por: Kaul, Subuhi, et al.
Publicado: (2020)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
por: Breithardt, Günter, et al.
Publicado: (2016)

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
por: Davis, Estella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ohm0s63o3d34626sgf72os961d